Company Profile
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company provides treatment solutions for viral and immune diseases in China and globally. The company offers recombinant human interferon alfa-2b injection.
Its portfolio also includes interferon alfa-2b vaginal effervescent tablets, coblopasvir hydrocholoride capsules, sofosbuvir tablets, peginterferon alfacon-2 injection, compound glycyrrhizin tablets, capsules, and injections, and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manufacture organization/contract development and manufacturing organization.
Its portfolio also includes technology and biotechnology development, technical consulting, biotechnology consulting, science and technology promotion and application, and wholesale of medical supplies. Beijing Kawin Technology Share-Holding Co., Ltd. was incorporated in 2008 and is based in Beijing, China.